We are live on
!
Find out more
MLICM
Metropolitan Life Insurance Company (MetLife) Portfolio holdings
AUM
$357M
1-Year Est. Return
13.97%
This Fund
S&P 500
This Quarter
Est. Return
+12.19%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$2.3B
AUM Growth
+$169M
(+7.9%)
Cap. Flow
-$19.9M
Cap. Flow
% of AUM
-0.86%
Top 10 Holdings %
Top 10 Hldgs %
31.98%
Holding
2,376
New
33
Increased
194
Reduced
1,525
Closed
69
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.36M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$3.41M |
| 3 |
Super Micro Computer
SMCI
|
+$1.52M |
| 4 |
Flutter Entertainment
FLUT
|
+$1.46M |
| 5 |
Deckers Outdoor
DECK
|
+$861K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$5.97M |
| 2 |
Apple
AAPL
|
+$1.75M |
| 3 |
Microsoft
MSFT
|
+$1.15M |
| 4 |
Meta Platforms (Facebook)
META
|
+$720K |
| 5 |
NVIDIA
NVDA
|
+$665K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.07% |
| 2 | Financials | 10.92% |
| 3 | Healthcare | 10.68% |
| 4 | Consumer Discretionary | 9.08% |
| 5 | Industrials | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EFC
1401
Ellington Financial
EFC
$1.76B
| $50.5K | ﹤0.01% |
4,277
| – | – |
|
|
CIM
1402
Chimera Investment
CIM
$993M
| $50.3K | ﹤0.01% |
3,638
-383
| -10% | -$5.34K |
|
1403
Repay Holdings
RPAY
$311M
| $50K | ﹤0.01% |
4,545
-213
| -4% | -$1.88K |
|
1404
Pediatrix Medical
MD
$2.15B
| $50K | ﹤0.01% |
4,982
| – | – |
|
1405
Protolabs
PRLB
$2.17B
| $49.9K | ﹤0.01% |
1,397
-189
| -12% | -$6.82K |
|
1406
Enact Holdings
ACT
$6.79B
| $49.9K | ﹤0.01% |
1,601
-299
| -16% | -$8.48K |
|
1407
Compass
COMP
$10.2B
| $49.8K | ﹤0.01% |
13,844
-1,374
| -9% | -$4.86K |
|
1408
Malibu Boats
MBUU
$576M
| $49.6K | ﹤0.01% |
1,146
| – | – |
|
|
DMC
1409
Del Monte Corp
DMC
$1.42B
| $49.5K | ﹤0.01% |
1,910
| – | – |
|
1410
Vir Biotechnology
VIR
$1.52B
| $49.3K | ﹤0.01% |
4,869
| – | – |
|
1411
Revolve Group
RVLV
$1.69B
| $49.3K | ﹤0.01% |
2,328
| – | – |
|
1412
Globalstar
GSAT
$10.8B
| $49.3K | ﹤0.01% |
2,235
-132
| -6% | -$3.2K |
|
1413
Vita Coco
COCO
$3.85B
| $49.2K | ﹤0.01% |
2,015
+164
| +9% | +$3.81K |
|
|
AVNS
1414
DELISTED
Avanos Medical
AVNS
| $49.2K | ﹤0.01% |
2,471
-438
| -15% | -$8.47K |
|
1415
Comstock Resources
CRK
$4.09B
| $49.1K | ﹤0.01% |
5,292
| – | – |
|
1416
QuinStreet
QNST
$1.19B
| $48.7K | ﹤0.01% |
2,758
| – | – |
|
1417
Core Laboratories
CLB
$571M
| $48.6K | ﹤0.01% |
2,848
| – | – |
|
|
ETNB
1418
DELISTED
89bio
ETNB
| $48.6K | ﹤0.01% |
4,178
+344
| +9% | +$3.81K |
|
1419
SiriusPoint
SPNT
$2.66B
| $48.6K | ﹤0.01% |
3,824
-155
| -4% | -$1.85K |
|
1420
Innoviva
INVA
$1.5B
| $48.5K | ﹤0.01% |
3,182
-693
| -18% | -$10.9K |
|
1421
Middlesex Water
MSEX
$1.1B
| $48.5K | ﹤0.01% |
923
-103
| -10% | -$5.7K |
|
1422
MacroGenics
MGNX
$259M
| $48.4K | ﹤0.01% |
3,285
| – | – |
|
1423
Regenxbio
RGNX
$720M
| $48.1K | ﹤0.01% |
2,284
| – | – |
|
1424
Aspen Aerogels
ASPN
$510M
| $48K | ﹤0.01% |
2,728
| – | – |
|
|
DCPH
1425
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $47.8K | ﹤0.01% |
3,038
| – | – |
|
Similar funds
RM
SPM
HCM
SFP
RIP
KLWA
LSC
5VM
Metropolitan Life Insurance Company (MetLife)'s Q1 2024 Portfolio in Review
As of Q1 2024, Metropolitan Life Insurance Company (MetLife) held 2,376 positions worth $2.3B, up 7.9% from $2.13B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 4.3%. Metropolitan Life Insurance Company (MetLife) opened 33 new positions and exited 69, leaving the 2,376-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Metropolitan Life Insurance Company (MetLife)'s largest Q1 2024 buy was Flutter Entertainment: 6,857 shares worth $1.37M.
- Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q1 2024, an estimated $8.36M increase.
- Metropolitan Life Insurance Company (MetLife)'s biggest Q1 2024 reduction was iShares MSCI EAFE ETF, cutting an estimated $5.97M.
- Metropolitan Life Insurance Company (MetLife) fully exited Immunogen Inc in Q1 2024, selling an estimated $403K.
- Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 32% of its $2.3B portfolio in Q1 2024.
- Metropolitan Life Insurance Company (MetLife) opened 33 new positions and closed 69 in Q1 2024.
- Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 7.9% quarter-over-quarter to $2.3B.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2024, filed 14 May 2024.